Haemonetics (HAE) Receivables - Other (2012 - 2018)

Haemonetics' (HAE) quarterly Receivables - Other came in at $5.0 million in Q1 2018, up 72.41% year-on-year from $2.9 million in Q1 2017, and little changed quarter-over-quarter from $5.0 million in Q4 2017.

Haemonetics (HAE) Receivables - Other (2012 - 2018) Analysis & Trends

Haemonetics' Receivables - Other history runs 3 years deep, the most recent figure standing at $5.0 million for Q1 2018.

  • On a quarterly basis, Receivables - Other rose 72.41% year-over-year to $5.0 million in Q1 2018; TTM through Mar 2018 was $5.0 million, a 72.41% increase from a year earlier, with the FY2018 full-year figure at $5.0 million, up 72.41% from the prior year.
  • Receivables - Other held at $5.0 million in Q1 2018 per HAE's latest filing, from $5.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $5.0 million in Q4 2017 and bottomed at $2.1 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Haemonetics 3.50 Bn 3.26 Bn 198.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2018 5.00 Mn
Mar 31, 2018 5.00 Mn
Dec 30, 2017 5.00 Mn
Dec 30, 2017 5.00 Mn
Sep 30, 2017 2.10 Mn
Sep 30, 2017 2.10 Mn
Jul 1, 2017 2.90 Mn
Jul 1, 2017 2.90 Mn
Apr 1, 2017 2.90 Mn
Apr 1, 2017 2.90 Mn
Dec 29, 2012 8.20 Mn
Dec 29, 2012 8.20 Mn
Sep 29, 2012 100,000.00
Sep 29, 2012 100,000.00
Mar 31, 2012 3.20 Mn
Mar 31, 2012 3.20 Mn